Scientific program

Day 1_September 19(Thu), 2019

Time Subject
17:00-17:10 Welcome AddressJeon, Seong Soo
17:10-17:40 Keynote Lecture Jeon, Seong Soo (Sungkyunkwan University)
  Immune checkpoint inhibitors for urothelial carcinomaNishiyama, Hiroyuki (Tsukuba University)
17:40-19:00 Prostate Cancer (1)Chair: Kwak, Cheol (Seoul Nat’l University)
Ogawa, Osamu (Kyoto University)
Uemura, Hirotsugu (Kindai University)
17:40-17:50 Urinary biomarker for detection and diagnosis of prostate cancerInoue, Takahiro (Kyoto University)
17:50-18:00 Active surveillance for prostate cancerSugimoto, Mikio (Kagawa University)
18:00-18:10 Post-treatment surveillance: beyond PSA, how far can we reach?Lu, Kevin (Taichung Veterans General Hospital)
18:10-18:20 Changing paradigms in the management of mPCWang, Shian-Shiang (Taichung Veterans General Hospital)
18:20-18:30 Androgen-deprivation therapy and risk of dementia in prostate cancer patientsShim, Myungsun (Hallym University)
18:30-18:40 The role of gut microbiota in patient with prostate cancer Lee, Hsiang-Ying (Kaohsiung Municipal Ta-Tung Hospital)
18:40-19:00 Q&A

Day 2_September 20(Fri), 2019

Time Subject
09:00-09:20 Introductory RemarksCho, Jin Seon / Nonomura, Norio / Chiang, Po Hui
Congratulatory RemarkAhn, Hanjong
09:20-10:20 Prostate cancer (2)Chair: Ahn, Hanjong (University of Ulsan)
Kakehi, Yoshiyuki (Kagawa University)
Ou, Yen-Chuan (Tung’s Taichung MetroHarbor Hospital)
09:20-09:30 Effect of Starting Penile Rehabilitation with Sildenafil Immediately after Robot-Assisted Laparoscopic Radical Prostatectomy on Erectile Function Recovery: A Prospective Randomized TrialJo, Jung Ki (Hanyang University)
09:30-09:40 Targeted focal cryotherapy for MRI-visible biopsy-proven primary clinically significant prostate cancerUkimura, Osamu (Kyoto Prefectural University)
09:40-09:50 Robotic-Assisted Radical Prostatectomy to Improve Cancer Control As Surgical Therapy for Prostate Cancer Shiroki, Ryoichi (Fujita Medical University)
09:50-10:00 Salvage HIFU, cryoablation or RT after primary treatment of PCALiu, Yi-Yang (Kaohsiung Chang Gung Hospital)
10:00-10:20 Q&A
10:20-10:40 Coffee Break 
10:40-11:50 Kidney cancerChair: Seo, Seong Il (Sungkyunkwan University)
Tomita, Yoshihiko (Niigata University)
Pang, ST Jacob (Chang Gung Memorial Hospital)
10:40-10:50 Delayed metastasis of RCC after surgical therapy and the response of target therapyLee, Chan Ho (Inje University)
10:50-11:00 The role of surgery in the treatment of metastatic kidney cancerEto, Masatoshi (Kyushu University)
11:00-11:10 Experience and result of cytoreductive nephrectomy and metastatectomy in mRCC Yang, Cheng-Kuang (Taichung Veterans General Hospital)
11:10-11:20 Metabolic features as a prognostic factor in patients with metastatic renal cell carcinomaYuk, Hyeong Dong (Inje University)
11:20-11:30 Development of personalized therapy for patients with clinicopathologically aggressive CpG island methylator phenotype clear cell RCCKitamura, Hiroshi (University of Toyama)
11:30-11:50 Q&A
11:50-13:30 Lunch
13:30-14:50 Urothelial Cancer Chair: Seo, Ho Kyung (Nat'l Cancer Center)
Nakagawa, Masayuki (Kagoshima University)
Chang, Hong-Chiang (Nat’l Taiwan University)
13:30-13:40 Liquid biopsy of urothelial carcinomaFujita, Kazutoshi (Osaka University)
13:40-13:50 Perioperative efficacy and long-term survival benefit of RARC in elderly patients: a nationwide study in JapanTakenaka, Atsushi (Tottori University)
13:50-14:00 Oncologic and perioperative outcomes of female radical cystectomy: results from a multicenter study in KoreaKang, Seok Ho (Korea University)
14:00-14:10 Preliminary result of combined MMC bladder instillation during RA-NUx with bladder cuff excisionHuang, Chi-Ping (China Medical University)
14:10-14:20 PD-L1 expression in upper tract urothelial carcinomaChiang, Po Hui (Kaohsiung Chang Gung Hospital)
14:20-14:30 PD-L1 expression status in Korean bladder urothelial carcinomaKim, Hyung Suk (Dongguk University)
14:30-14:50 Q&A
14:50-15:10 Coffee Break
15:10-15:40 Research (1)Chair: Cho, Jin Seon (Hallym University)
Horie, Shigeo (Juntendo University)
Wu, Wen-Jeng (Kaohsiung Medical University)
15:10-15:20 Significant role of PHDGH as a key enzyme for serine biosynthesis in advanced urologic cancersEnokida, Hideki (Kagoshima University)
15:20-15:30 Overall dysfunction of T cells significantly correlates with tumor grade in Renal Cell Carcinoma patientsKawashima, Atsunari (Osaka University)
15:30-15:40 The prognostic significance of circulating tumor cells in prostate cancerKim, Sung Han (National Cancer Center)
15:40-15:50 Coffee Break
15:50-16:35 Research (2)Chair: Kim, Sun Il (Ajou University)
Nonomura, Norio (Osaka University)
15:50-16:00 Translational research on drug therapy for urothelial cancerKobayashi, Takashi (Kyoto University)
16:00-16:10 Genome-directed urothelial carcinoma model help predict drug response and establish treatment strategyLuo, Hao-Lun (Kaohsiung Chang Gung Hospital)
16:10-16:15 Prothymosin-α enhances PTEN expression and binds with TRIM-21 to regulate Keap1/Nrf2 signaling in human bladder cancerTsai, Yuh-Shyan (Nat'l Cheng Kung University)
16:15-16:35 Q&A
16:35-16:45 Closing RemarkCho, Jin Seon